|Publication number||US3665064 A|
|Publication date||May 23, 1972|
|Filing date||May 9, 1969|
|Priority date||Jan 5, 1967|
|Publication number||US 3665064 A, US 3665064A, US-A-3665064, US3665064 A, US3665064A|
|Inventors||Day Joe L, Mosier Benjamin|
|Export Citation||BiBTeX, EndNote, RefMan|
|Referenced by (18), Classifications (8)|
|External Links: USPTO, USPTO Assignment, Espacenet|
United States Patent 1151 3,665,064 Mosier et a1. 5] May 23, 1972  METHOD OF MAKINGA PERSPIRATION RESISTANT References Cited BIOPOTENTIAL ELECTRODE UNITED STATES PATENTS 1 lnvemorSI Belliamin M061"; Joe Day, both of 2,692,904 10/1954 Strauss ..106/2o9 HoustomTeX- 3,111,478 11/1963 Watanabe 3151619 10/1964 Sullivan  Ass1gnee. The United States of Amerlca as 3,156,011 11/1964 Olson by the 3,187,745 6/1965 Baum etal 12s/417 National Aeronautics and Space Administration Filed: May 9, 1969 Appl. No.: 844,225
Related U.S. Application Data Division of Ser. No. 607,461, Jan. 5, 1967, Pat. No. 3,490,440.
U.S. Cl ..264/l04, 106/209, 128/2.1,
128/417, 252/514 Int. Cl. ..A6lb 5/04 Field ofSearch ..264/104; 128/21, 21,417;
Primary Examiner-Julius Frome Assistant Examiner-John H, Miller Attorney-G. F McCoy and Marvin F. Matthews  ABSTRACT To a conventional biopotential electrode mixture is added 5-15 percent of a colloidal material which acts as a screen for undesirable ions resulting from perspiration. This colloidal ion screening material is selected from a group consisting of various gums, bentonite clay, and a magnesium aluminum silicate clay-like material, The mixture is pressed into shape around an electrode wire after being subjected to a partial vacuum.
2 Claims, 2 Drawing Figures PUMP Patented May 23, 1972 PUMP flan 140707 MdJ// afoe A flay INVENTORJ AT/DP/VA'VS METHOD OF MAKING A PERSPIRATION RESISTANT BIOPOTENTIAL ELECTRODE RELATED APPLICATIONS This application is a division of our co-pending application, Ser. No. 607,461, filed Jan. 5, 1967, now US. Pat. No. 3,490,440.
ORIGIN OF THE INVENTION The invention described herein was made in the performance of work under a NASA contract and is subject to the provisions of Section 305 of the National Aeronautics and Space Act of 1958, Public Law 85-568 (72 Stat. 435; 42 U.S.C. 2457).
SUMMARY OF PROBLEM AND SOLUTION Primary requirements in biopotential electrodes include relative comfort for the observed subject, minimum skin-electrode junction resistance, and minimum skin-electrode junction potential. An important additional factor is the requirement that biopotential electrodes maintain reliable data output during long monitoring experiments which requires that chemical poisoning of the electrode be held to a minimum. By chemical poisoning, reference is made to the fact that the electrode is customarily attached to the skin of the subject and the electrode is sometimes poisoned by the products of perspiration from the skin of the subject. The products of perspiration typically include simple salts which ionize relatively easy, and complex protein molecules which are substantially large and which do not ionize easily. The above-noted requirements have been dealt with in a less satisfactory manner in times past, and the apparatus of the prior art have been generally found wanting.
It is common to refer to the Calomel electrode which is considered to be an industry standard. The present invention compares very favorably with the standard Calomel electrode in numerous regards as will be noted. For instance, stability of the junction potential is substantially better than that of the Calomel standard electrode over relatively short or long test periods. Also, long-term poisoning effects are substantially improved by the present invention. With the problems of the prior art in view, and as indicated by specifications hereof, the preferred embodiment is summarized as providing a pressed electrode formed of intimately commingled powers of relatively small size in which silver, silver halogen salt, and a colloidal material comprising an ion screening means are pressed to form the pressed electrode of the present invention.
Therefore, an object of the present invention is to provide a new and improved pressed disc electrode provided with ion screen means for excluding large protein molecules from the electrode to prevent poisoning effects.
Another object of the present invention is to provide a new and improved pressed electrode for biopotential applications wherein movement of ions is permitted by ion screening means to communicate the electrical signal from the skin to the electrode.
Another object of the present invention is to provide a new and improved biopotential electrode in which junction resistance and junction potential between the skin and the electrode are materially altered to permit passage of the biopotential signal with minimum noise from the electrode.
Yet another object of the present invention is to provide a new and improved method of manufacturing electrodes in which the electrode shape is determined without machining wherein the method of fabricating the electrode includes the step of forming the electrode by pressing particle constituents together.
An important object of the present invention is to provide a new and improved method of forming electrodes in which water and other dissolved materials are removed from the raw ingredients of the electrode prior to forming.
An important object of the present invention is to provide a new and improved method of forming electrodes without intemal stresses which commonly occur in machining techniques.
Other objects and advantages of the present invention will become more readily apparent from a consideration of the following specification and drawings wherein:
FIG. 1 is an isometric view of means for forming the electrode of the present invention with a section broken away; and FIG. 2 is the completed electrode of the present invention.
Considering the invention in detail, attention is first directed to FIG. 1 of the drawings which illustrates apparatus for forming the biopotential electrode of the present invention. In FIG. 1, the forming apparatus is indicated generally at 10 and includes a lower die piece 12 for preferably receiving silver, silver chloride, and colloidal material therein as indicated at 14. The material 14 is granulated and is placed in the pie piece 12 as will be described in greater detail hereinafter. The finished electrode requires electrical connection to monitoring apparatus, and to this end, an electrode wire 16 having a bared conductor 18 is positioned as illustrated in FIG. 1 whereby the conductor 18 is intimately associated with the interior of the completed biopotential electrode. The wire 18 is joined to the electrode by the pressing technique which will be described in greater detail hereinafter.
The upper portions of the mold are completed by the die piece 20 which mates with the piece 12 to provide a generally cylindrical chamber for receiving the granulated material 14 therein. At the seam between the pieces 12 and 20, a hole is provided of appropriate diameter for receiving the electrical conductor 18 therein. A slidable pressure plate 22 is received within the bore of the assembled mold and is adapted to impart substantial pressures to the powdered, granulated material 14 in the mold. The pressure plate 22 is moved longitudinally of the bore in response to urging of apparatus which will be described.
Of particular interest to the present invention is the combination of silver and silver chloride serving as the conducting metal and halogen salt of the electrode. Silver chloride is quite active chemically, and to this end, the mold is made of noncorrosive materials. By way of example, teflon, nylon or zirconium are non-corrosive materials which do not suffer from close, intimate contact with the silver chloride. Moreover, the use of nylon or teflon, at least to the extent of lining the mold dies, enables separation of the completed pressed electrode which is easily freed from the die after compression. In this regard, the die pieces are formed of heavy gauge metal to provide substantial strength to the mold and the pieces are plated or lined with the above noted non-corrosive materials.
Attention is re-directed to FIG. 1 which illustrates a vacuum chamber 24 surrounding the mold in which the electrode is assembled. The vacuum chamber 24 is of substantial size and is quite adequate if it accommodates the mold therein in somewhat the manner shown in FIG. 1. Of course, the vacuum chamber 24 fully encompasses the mold to enable a vacuum to be maintained about the particle materials in the chamber for purposes to be noted. While the mold is located within the vacuum chamber 24, the apparatus for providing a compressive force to the material 14 is preferably located exteriorly of the vacuum chamber 24, and to this end, a plunger or movable piston 26 is included for communicating a compressive force to the mold to compact the particles 14 into a solid electrode. The shaft or piston 26 passes through the vacuum chamber 24 by means of a packing gland 28 or other appropriate means for maintaining the vacuum within the chamber 24. An axial force is applied to the upper end of the piston 26 whereby the force is communicated to the pressure plate 22 for compacting the particles 14 in the mold.
Of course, conventional hydraulic apparatus can be used for applying the axial load to the shaft 26. That is, a hydraulic press or other equivalent means provides a force having an equivalent pressure of about 8,000 to 50,000 pounds per square inch on the electrode material 14.
A vacuum conduit 30 communicates the vacuum chamber 24 with a vacuum pump (not shown) for evacuating the chamber 24. The vacuum pump is of conventional construction for substantially evacuating the chamber 24. It has been discovered that the silver and salt mixture placed in the mold tends to absorb water and dissolved gases. The finished biopotential electrode usually suffers due to the inclusion of these extraneous materials in the finished product. The use of the evacuated chamber 24 draws the dissolved gas and water from the granulated materials 14. An acceptable level of vacuum is evacuation to approximately 1 to milimeters of mercury.
In considering operation of the vacuum on the granulated particles 14, it should be noted that the fit of the pressure plate 22 within the mold piece 20 has some tolerance to permit escape of dissolved gases or water in the particles 14 within the mold. Contrariwise, if the pressure plate 22 sealed the mold perfectly, it would be impossible to remove water from the granulated particles 14 by the use of the vacuum pumpand technique above noted.
To this end, nominal clearance is provided between the pressure plate 22 and the surrounding mold even at the expense of a few particles of granulated material escaping from the mold when pressure is applied.
Attention is directed to FIG. 2 of the drawings which illustrates the completed or finished electrode 36. The electrode is finished after evacuating the chamber 24 and thereafter applying pressure having an equivilent pressure of approximately 8,000 to 50,000 pounds per square inch on the electrode material 14. Pressure is maintained on the granulated materials for an interval of time of approximately one to three minutes. Moreover, the completed electrode 36 is prepared for installation and use on a subject to obtain biopotential signals as in EKGs, EEGs, or the like,
The method of the present invention has been generally described hereinabove, but additional details are presently noted. Of interest is the fineness of the particles 14 placed in the mold and the effect of particles too large or too small on the completed electrode. For instance, the silver chloride should be ground to at least 200 mesh, since the smoothness of the finished pellet or electrode depends on the fineness of the silver chloride particles. As a matter of fact, 325 to 400 mesh silver chloride is commercially available and is recommended for high quality pellets. On the other hand, grinding too finely increases the propensity to absorb water into the granulated particles 14. After the products have been ground, it is preferable to intimately mix the metal and metal halogen salt with further grinding. Reference is made to micropulverizer means as a means for substantially cornmingling the metal and metal salt. Use of micropulverizer means yields particles having a diameter of approximately microns. If possible, particle less than 10 microns are quite acceptable to the extent that excessive water absorption is not encountered.
Attention is next directed to the preferred components of the present invention and percentages of the preferred embodiment. The preferred materials of the present invention include a mixture of approximately 90 percent silver and approximately 10 percent silver chloride. The mixture may vary to include perhaps as little as 4 percent or 5 percent silver chloride to a preferred maximum of approximately 20 percent silver chloride. The other halogen salts of silver are quite acceptable, although the silver chloride is the preferred salt. Also, other conducting metals have been used experimentally, but silver is the preferred basic ingredient in the biopotential electrode.
Added to the silver and silver chloride is a selected percentage of the colloidal material. The colloidal material provides the ion screening means in the completed electrode. The silver and silver salt preferably constitute about 90 percent of the mixture, and the colloidal material the other 10 percent. Again, the colloidal material can vary over a range of perhaps 5 percent to percent.
The colloidal material is preferably selected from two groups described in detail below. Of particular interest is the group which is best denoted as plant hydrocolloids. Natural plant hydrocolloids are commonly water soluble gums or stabilizers which are generally carbohydrates derived from plant sources. Chemically, the plant hydrocolloids are usually polysaccharides or salts of polysaccharides. Their common properties include the formation of viscous solutions, or more accurately, colloidal sols or gels in water. In electrodes, common characteristics generally are the ability to improve the body, convey elasticity and texture, impart emollient properties, and stabilize the completed electrode of the present invention. Several plant hydrocolloids will be noted hereinbelow.
Guar gum is a straight chain mannon branched at regular intervals with a single membered galactose units or alternate mannose units. The long straight chain of this molecule, combined with its regular side branching, is unique among the natural colloids and should be beneficial as an ion-exchange material to be incorporated in the biopotential electrode. The molecular weight is in the area of 220,000. Agar-agar is a plant hydrocolloid which is generally insoluble in cold water, and is also a completely reversible hydrocolloid. Agar-agar is believed to be a linear polygalactose sulfuric ester. It seems likely that agar-agar is a calcium polygalactopyranose complex. Basic constituents seem to include calcium, magnesium, sodium, and potassium.
Gum arabic is a complex mixture of calcium, magnesium and potassium salt of arabic acid. Arabic acid is a complex of galactose, rhamnose, arabinose, and glucosonic acid. The molecular weight of gum arabic is on the order of about 240,000.
Gum tragacanth is a soluble portion tragacanthen and includes an insoluble portion, borsorin, wherein the borsorin is approximately 60 to 70 percent of the total volume by weight. Tragacanthen comprises a ring containing three molecules glucosonic acid and one molecule arabinose with a side chain of two molecules of arabinose. Gum tragacanth apparently contains small amounts of cellulose starch and protein substances.
Gum ghatti is amphorous translucent water soluble complex polysaccharide. It has good film forming properties and is a good binder for silver-silver chloride electrodes.
Locust beam gum is a polysaccharide built up of a main chain of mannose units with short branching single galactose units. The molecular weight is about 310,000.
Gum karaya is a complex polysaccharide of high molecular weight perhaps on the order of 9,500,000. On hydrolosis it yields galactose, rhamnose and galactorinic.
An additional class of colloidal materials may be generally described as clay or clay like materials which customarily include substantial quantities of aluminum silicates. One such material is bentonite clay which is commercially sold under the trade name Zeogel. The Zeogel product is a modified montmorillanite which yields substantial stability and minimum resistivity in the completed electrode An additional clay-like product suitable for use is Veegum, a trade name of R. T. Vanderbilt Company, New York, N. Y., for an inorganic, colloidal, magnesium aluminum silicate. The raw materials for Veegum are mined in the Death Valley region of the Funeral Mountains at the border of Nevada and California, and subsequently refined. The average chemical analysis of Veegum conventionally expressed as oxides is as follows:
Silicon Dioxide 61.1% Magnesium Oxide 13.7 Aluminum Oxide 9.3 Titanium Dioxide 0.1 Ferric Oxide 0.9 Calcium Oxide 2.7 Sodium Oxide 29 Potassium Oxide 0.3 Carbon Dioxide 1.8 Water of Combination 7.2
The foregoing examples of the colloidal material indicate the operation of the ion screening means in the electrode. When the colloidal material is added to the silver and silver salt, and the electrode is formed in the hydraulic press, the disbursion of the ion screening means throughout the electrode provides a means whereby selective ion movement is permitted into and out of the electrode. In the conventional installation of the electrode, the electrode is placed adjacent the skin of a subject to obtain biopotential signals therefrom. Such placement enables the electrode to obtain signals from the skin by means of ion interchange therebetween. In long term monitoring applications, the great likelihood is that the subject will perspire to a greater or lesser extent at the skin. This places additional ions between the skin and the electrode which complicate the chemistry of the junction. The complicating factors result from a multitude of reasons. For instance, the products of perspiration generally include relatively simple salts which ionize easily and provide additional ion carriers for the current between the skin and the electrode. The ion screening means of the present invention permits the current to flow to the electrode without limiting the current or without increasing the ohmic resistance of the skin-electrode junction. Also, the produce of perspiration include complex protein molecules which are detrimental in two regards. In the first instance, the protein molecules are substantially large and generally tend to block the pores of the electrode. Secondly, and of greater importance, is the fact that large protein molecules combine to form non-ionizing compounds in the electrode which provide a long term poisoning effect. The ion screening means of the present invention prevents the large protein molecules from chemical interaction with the electrode and therefore prevents the poisoning effect. Also, the
ion screening means of the present invention seems to lower the skin-junction electrode resistance and potential.
While the foregoing describes the preferred embodiment of the present invention, the scope thereof is defined by the appended claims.
What is claimed is:
1. A method for forming a biopotential electrode comprising the steps of:
a. mixing intimately small particles of silver, a silver halide, and an ion screening colloidal material selected from the group consisting of guar gum, agar-agar, gum arabic, gum tragacanth, gum ghatti, locust beam gum, gum karaya, bentonite clay, and colloidal magnesium aluminum silicate clay, said ion screening material representing about 5 to 15 percent by weight of the mixture;
b. placing said mixed particles in a press means of a noncorrosive material;
c. positioning one end of an electrode wire so that it is intimately associated with the interior of the mixed particles;
d. reducing the atmospheric pressure surrounding the mixed particles so as to allow outgassing of absorbed water and dissolved gases;
e. applying pressure to said particles and electrode wire end to form an electrode body; and
f. removing the completed electrode from said press means.
2. The method of claim 1 wherein the small particles are at least 200 mesh; the atmospheric pressure is reduced to approximately 1 to 5 milimeters of mercury; and a pressure in the approximate range of 8,000 to 50,000 pounds per square inch is applied to the small particles for approximately 1 to 3 minutes.
|Citing Patent||Filing date||Publication date||Applicant||Title|
|US3834373 *||Feb 24, 1972||Sep 10, 1974||Sato T||Silver, silver chloride electrodes|
|US3835210 *||Apr 16, 1973||Sep 10, 1974||Trw Inc||Method of forming powder compacts|
|US3993049 *||Dec 26, 1974||Nov 23, 1976||Kater John A R||Electrodes and materials therefor|
|US4125110 *||Nov 7, 1977||Nov 14, 1978||Hymes Alan C||Monitoring and stimulation electrode|
|US4270543 *||Oct 9, 1979||Jun 2, 1981||Tdk Electronics Co., Ltd.||Silver-silver chloride electrode|
|US4274420 *||Oct 12, 1978||Jun 23, 1981||Lectec Corporation||Monitoring and stimulation electrode|
|US4299231 *||Nov 13, 1979||Nov 10, 1981||Beiersdorf Aktiengesellschaft||Electrically conductive, visco-elastic gel and its use in electrode|
|US4473492 *||Jun 6, 1983||Sep 25, 1984||Basf Wyandotte Corporation||Electrode cream|
|US4682995 *||Mar 6, 1986||Jul 28, 1987||U.S. Philips Corporation||Method for the manufacture of glass bodies by extrusion|
|US4685946 *||Mar 25, 1986||Aug 11, 1987||U.S. Philips Corporation||Method for the manufacture of glass bodies|
|US4838273 *||Jun 22, 1987||Jun 13, 1989||Baxter International Inc.||Medical electrode|
|US4955382 *||Apr 3, 1989||Sep 11, 1990||Ep Technologies||Apparatus and method for recording monophasic action potentials from an in vivo heart|
|US4979510 *||Jul 27, 1988||Dec 25, 1990||Ep Technologies, Inc.||Apparatus and method for recording monophasic action potentials from an in vivo heart|
|US5423878 *||Aug 2, 1993||Jun 13, 1995||Ep Technologies, Inc.||Catheter and associated system for pacing the heart|
|US6898465||Oct 17, 2001||May 24, 2005||The Ludlow Company Ip||Differential gel body for a medical stimulation electrode|
|US20030074042 *||Oct 17, 2001||Apr 17, 2003||The Ludlow Company||Differential gel body for a medical stimulation electrode|
|USRE31454 *||Nov 12, 1980||Dec 6, 1983||Lectec Corporation||Monitoring and stimulation electrode|
|WO1990000878A1 *||Jul 27, 1989||Feb 8, 1990||Ep Technologies||Apparatus and method for recording monophasic potentials|
|U.S. Classification||264/104, 600/396, 252/514, 106/205.9|
|Cooperative Classification||A61B2562/125, A61B5/0408|